EDGAR Filing Documents for 0001193125-23-182776

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-23-182776

Filing Date

2023-07-06

Accepted

2023-07-06 16:06:14

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	d473990d424b5.htm	424B5	378856
2	GRAPHIC	g473990g04a00.jpg	GRAPHIC	46931
3	GRAPHIC	g473990g08a00.jpg	GRAPHIC	74325
	Complete submission text file	0001193125-23-182776.txt		536662

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301

Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519

Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-272909 | Film No.: 231073627
SIC: 2834 Pharmaceutical Preparations